Runqing Lu

2.5k total citations
36 papers, 2.0k citations indexed

About

Runqing Lu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Runqing Lu has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Runqing Lu's work include Immune Cell Function and Interaction (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and T-cell and B-cell Immunology (6 papers). Runqing Lu is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and T-cell and B-cell Immunology (6 papers). Runqing Lu collaborates with scholars based in United States, China and Israel. Runqing Lu's co-authors include Ginette Serrero, Paula M. Pitha, Shibin Ma, Long Trinh, Simanta Pathak, D W Lancki, Harinder Singh, Kay L. Medina, Vipul Shukla and S. K. Joshi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Runqing Lu

36 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Runqing Lu United States 23 797 759 444 233 223 36 2.0k
Keishi Fujiwara Japan 21 316 0.4× 983 1.3× 319 0.7× 248 1.1× 109 0.5× 38 2.0k
Sathish Kumar Mungamuri India 20 374 0.5× 1.2k 1.6× 554 1.2× 294 1.3× 62 0.3× 42 1.9k
Antônio Palumbo Brazil 21 265 0.3× 676 0.9× 277 0.6× 285 1.2× 151 0.7× 47 1.4k
Gabriela Brumatti Australia 24 912 1.1× 1.3k 1.6× 297 0.7× 261 1.1× 91 0.4× 40 2.2k
Sophie Raynaud France 25 306 0.4× 1.2k 1.6× 458 1.0× 202 0.9× 316 1.4× 86 2.8k
Yongdong Feng China 26 326 0.4× 972 1.3× 641 1.4× 397 1.7× 157 0.7× 64 1.7k
Eliana Abdelhay Brazil 26 244 0.3× 1.1k 1.5× 474 1.1× 452 1.9× 111 0.5× 125 2.0k
David Segal Australia 21 464 0.6× 1.0k 1.4× 429 1.0× 167 0.7× 206 0.9× 38 1.9k
David M. Tillman United States 27 800 1.0× 1.2k 1.6× 604 1.4× 232 1.0× 160 0.7× 52 2.5k
Nandini Kishore United States 15 690 0.9× 451 0.6× 601 1.4× 356 1.5× 110 0.5× 20 1.9k

Countries citing papers authored by Runqing Lu

Since Specialization
Citations

This map shows the geographic impact of Runqing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runqing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runqing Lu more than expected).

Fields of papers citing papers by Runqing Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runqing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runqing Lu. The network helps show where Runqing Lu may publish in the future.

Co-authorship network of co-authors of Runqing Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Runqing Lu. A scholar is included among the top collaborators of Runqing Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runqing Lu. Runqing Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Tiantian, Runqing Lu, Yingmei Li, et al.. (2024). Venetoclax combined chemotherapy versus chemotherapy alone for acute myeloid leukemia: a systematic review and meta-analysis. Frontiers in Oncology. 14. 1361988–1361988. 1 indexed citations
2.
Lu, Runqing, Dingming Wan, Xinsheng Xie, et al.. (2023). Effects of post-transplant maintenance therapy with decitabine prophylaxis on the relapse for acute lymphoblastic leukemia. Bone Marrow Transplantation. 58(6). 687–695. 5 indexed citations
3.
Lu, Runqing, et al.. (2022). SGK1, a Critical Regulator of Immune Modulation and Fibrosis and a Potential Therapeutic Target in Chronic Graft-Versus-Host Disease. Frontiers in Immunology. 13. 822303–822303. 19 indexed citations
4.
Wan, Dingming, Weijie Cao, Haizhou Xing, et al.. (2022). Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma. Scientific Reports. 12(1). 6752–6752. 18 indexed citations
5.
Haney, Staci L., Jana Opavska, David Klinkebiel, et al.. (2016). Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a. Cell Reports. 15(6). 1190–1201. 28 indexed citations
6.
Yin, Detao, Kun Yu, Runqing Lu, et al.. (2016). Prognostic impact of minimal extrathyroidal extension in papillary thyroid carcinoma. Medicine. 95(52). e5794–e5794. 39 indexed citations
7.
Shukla, Vipul, et al.. (2016). Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia. Oncotarget. 7(27). 41081–41094. 15 indexed citations
8.
Shukla, Vipul & Runqing Lu. (2014). IRF4 and IRF8: governing the virtues of B lymphocytes. Frontiers in Biology. 9(4). 269–282. 33 indexed citations
9.
Shukla, Vipul, Shibin Ma, S. K. Joshi, & Runqing Lu. (2014). Notch2 Is Critical for CLL Development in the IRF4-/-Vh11 Mice. Blood. 124(21). 891–891. 2 indexed citations
10.
Mittal, Amit, Nagendra K. Chaturvedi, Tara M. Nordgren, et al.. (2014). Chronic Lymphocytic Leukemia Cells in a Lymph Node Microenvironment Depict Molecular Signature Associated with an Aggressive Disease. Molecular Medicine. 20(1). 290–301. 52 indexed citations
11.
Ma, Shibin, et al.. (2013). Accelerated Development of Chronic Lymphocytic Leukemia in New Zealand Black Mice Expressing a Low Level of Interferon Regulatory Factor 4. Journal of Biological Chemistry. 288(37). 26430–26440. 19 indexed citations
12.
Pathak, Simanta, Shibin Ma, Long Trinh, et al.. (2011). IRF4 Is a Suppressor of c-Myc Induced B Cell Leukemia. PLoS ONE. 6(7). e22628–e22628. 36 indexed citations
13.
Lu, Runqing. (2008). Interferon regulatory factor 4 and 8 in B-cell development. Trends in Immunology. 29(10). 487–492. 86 indexed citations
14.
Ma, Shibin, et al.. (2006). IFN Regulatory Factor 4 and 8 Promote Ig Light Chain κ Locus Activation in Pre-B Cell Development. The Journal of Immunology. 177(11). 7898–7904. 74 indexed citations
15.
Lu, Runqing, Kay L. Medina, D W Lancki, & Harinder Singh. (2003). IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes & Development. 17(14). 1703–1708. 202 indexed citations
16.
Lu, Runqing, Paul A. Moore, & Paula M. Pitha. (2002). Stimulation of IRF-7 Gene Expression by Tumor Necrosis Factor α. Journal of Biological Chemistry. 277(19). 16592–16598. 53 indexed citations
17.
Lu, Runqing & Paula M. Pitha. (2001). Monocyte Differentiation to Macrophage Requires Interferon Regulatory Factor 7. Journal of Biological Chemistry. 276(48). 45491–45496. 80 indexed citations
18.
Lu, Runqing, Wei-Chun Au, Wen-Shuz Yeow, N. Hageman, & Paula M. Pitha. (2000). Regulation of the Promoter Activity of Interferon Regulatory Factor-7 Gene. Journal of Biological Chemistry. 275(41). 31805–31812. 138 indexed citations
19.
Lu, Runqing & Ginette Serrero. (1999). Stimulation of PC Cell-Derived Growth Factor (Epithelin/Granulin Precursor) Expression by Estradiol in Human Breast Cancer Cells. Biochemical and Biophysical Research Communications. 256(1). 204–207. 47 indexed citations
20.
Lu, Runqing & Ginette Serrero. (1999). Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. Journal of Cellular Physiology. 179(3). 297–304. 286 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keishi Fujiwara Breakdown of academic impact, for papers by Sathish Kumar Mungamuri Breakdown of academic impact, for papers by Antônio Palumbo Breakdown of academic impact, for papers by Gabriela Brumatti Breakdown of academic impact, for papers by Sophie Raynaud Breakdown of academic impact, for papers by Yongdong Feng Breakdown of academic impact, for papers by Eliana Abdelhay Breakdown of academic impact, for papers by David Segal Breakdown of academic impact, for papers by David M. Tillman Breakdown of academic impact, for papers by Nandini Kishore
Rankless by CCL
2026